Managing Director of Elos Medtech Tianjin is appointed

Conny Jakobsson is appointed as Managing Director of Elos Medtech Tianjin. Conny has 17 years’ experience from leading positions in China, primarily within production, purchasing and sourcing. Conny brings with him a broad experience and knowledge of both the market and the Chinese culture. He joins Elos Medtech from his role as president of a Chinese company which produces cutting tools and sales of CNC grinding machines. He assumes his new position in early October 2017.

Conny Jakobsson has years of experience from leading positions at manufacturing international companies. After a degree in economics at the University of Stockholm, he worked at Ericsson and Flextronics within sourcing before he chose to work and settle in China 17 years ago.

"We are delighted to welcome Conny to our business in China. With his production background and his focus on quality and customers’ need, we look forward to using the breadth of Conny’s experience to realize our growth ambitions and strategic goals at the Asian market. Our assessment is that Elos Medtech Tianjin has the potential to be further developed as an attractive partner to the global medical technology market”, says Jan Wahlström, CEO and president of Elos Medtech.

Elos Medtech is one of the leading development and production partners for medical technology products and components in the world, such as dental and orthopaedic implants and instruments. The operations are conducted at facilities in Sweden, Denmark, China and the US. Customers are internationally active medical technology companies.

Elos Medtech Group’s turnover is approximately MSEK 550 and has about 520 employees. The Group has been traded on NASDAQ Stockholm AB since 1989. The Elos Medtech B share is classified as a Health Care company on the Small Cap list.

Gothenburg, September 25, 2017

Elos Medtech AB (publ)

For further information, contact:

Jan Wahlström, President and CEO, +46 70-212 18 89, jan.wahlstrom@elosmedtech.com


 

This is the type of information that Elos Medtech AB (publ) is obliged to publish in accordance with the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was issued for publication by the contact persons stated above on September 25, 2017, at 19.00  (CET).

For additional information about the Elos Medtech Group, visit www.elosmedtech.com 

Tags: